Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO16432-D1

Biomarker Field of development:

Melanoma Therapy Area:

Target Type of patent:

Methods and compositions for treating melanoma

The present invention relates to a method and composition for treating melanoma. More particularly, inventors have shown that high expression of USP14 […]

BIO19224-D1

Biomarker Field of development:

Obesity Therapy Area:

Biomarker Type of patent:

Use of new biomarker for selecting and determining response to

Exercise improves metabolic health and prevents the complications of obesity and type 2 diabetes. The inventors hypothesized that skeletal muscle […]

BIO19287-D1

Biomarker Field of development:

Arteriosclerosis/Atherosclerosis Therapy Area:

Method Type of patent:

Methods of determining whether a subject is at risk of developing

Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds low-density lipoprotein receptor (LDLR), preventing its recycling. PCSK9 is a risk […]

BIO17093-D1

Biomarker Field of development:

Cystic Fibrosis Therapy Area:

Method Type of patent:

Methods for predincting the risk of developing pulmonary

The present invention relates to methods for predicting the risk of developing pulmonary colonization/infection by P. aeruginosa. The inventors […]

BIO19208-T1

Drug Field of development:

Glomerulonephritis Therapy Area:

Target Type of patent:

Use of cd9 as a biomarker and as a biotarget in glomerulonephritis

The mechanisms driving the development of extracapillary lesions in focal segmental glomerulosclerosis (FSGS) and crescentic glomerulonephritis (CGN) […]

BIO17093-D2

Biomarker Field of development:

Cystic Fibrosis Therapy Area:

Method Type of patent:

Methods for predincting the risk of developing pulmonary

The present invention relates to methods for predicting the risk of developing pulmonary colonization/infection by P. aeruginosa. The inventors […]

BIO18523-D1

Biomarker Field of development:

Sepsis / Septic Shock Therapy Area:

Biomarker Type of patent:

New biomarker for prognosis and response to corticoid in patients with

Septic shock is the leading cause of death in intensive care units. Previous studies have highlighted the immunosuppressive protein GILZ […]

BIO17511-D1

Biomarker Field of development:

Prostate Cancer Therapy Area:

Biomarker Type of patent:

Prognosis and treatment of patients suffering from prostate cancer

The invention relates to methods for predicting the outcome of a patient suffering from prostate cancer and methods for the treatment of prostate […]

BIO15495-D1

Biomarker Field of development:

Solid Tumors Therapy Area:

Biomarker Type of patent:

Pd-1 and tim-3 expression as biomarkers for predicting survival time

Kidney cancer also called "renal cancer," or "renal cell carcinoma" (RCC) refers to cancer that has arisen from the kidney, and is […]

BIO11338-D1

Biomarker Field of development:

Solid Tumors Therapy Area:

Biomarker Type of patent:

Follicular b cell, cd8+ t cell, treg and dendritic cell density for

Lung cancer is the most common cause of cancer related death in the world. Approximately 80% to 90% of cases involve Non–Small-Cell Lung Cancer […]

147

56

310

46

Our Technology Offers

Methods and compositions for treating melanoma

Use of new biomarker for selecting and determining response to

Methods of determining whether a subject is at risk of developing

Methods for predincting the risk of developing pulmonary

Use of cd9 as a biomarker and as a biotarget in glomerulonephritis

Methods for predincting the risk of developing pulmonary

New biomarker for prognosis and response to corticoid in patients with

Prognosis and treatment of patients suffering from prostate cancer

Pd-1 and tim-3 expression as biomarkers for predicting survival time

Follicular b cell, cd8+ t cell, treg and dendritic cell density for

You might also be interested in

Use of ngal inhibitors for treating chronic wound

A clec12b antagonist for treating

Use of myeloperoxidase inhibitors for the

Methods and compositions for treating melanoma

Use of new biomarker for selecting and determining

Methods of determining whether a subject is at

Hla-class ii artificial antigen presenting cells

Transoesophageal device using high intensity

Recombinant flagellin for preventing and treating

Histone chaperone hira inhibitor for treating

Methods and topical pharmaceutical compositions

Mutated strain for the development of attenuated